Eli Lilly Raises Full Year Outlook amid Q2 2023 Profit Surge of 85%
Eli Lilly’s success can be ascribed in part to its promising medical pipeline and strategic acquisitions.
Eli Lilly’s success can be ascribed in part to its promising medical pipeline and strategic acquisitions.